Stock BINV BIOINVENT INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BioInvent International AB

Equities

BINV

SE0015244520

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:36 2024-04-26 am EDT 		5-day change 1st Jan Change
25.15 SEK +1.62% Intraday chart for BioInvent International AB +6.12% +32.65%
Apr. 24 BioInvent International AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 BioInvent, Merck & Co. Unit Sign Clinical Trial, Supply Deal for Tumor Treatment as Add-On Therapy for Keytruda MT

Evolution of the average Target Price on BioInvent International AB

Price target over the last 5 years

History of analyst recommendation changes

8aa43360afc.yunL6hYI_M5A6gdyOn4W533X82aCT3x20NI2N6S9u88._6qjhXl9uYQnn1QtAzZeikyRlQO2Hh4aquJ-fejN1Z6Nq6i-bmSuvgWEZA~eea52070ca9c4a9924894528eee43a8e

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
25.15 SEK
Average target price
83 SEK
Spread / Average Target
+230.02%
High Price Target
83 SEK
Spread / Highest target
+230.02%
Low Price Target
83 SEK
Spread / Lowest Target
+230.02%

Consensus detail

Consensus revision (last 18 months)

Ratings for BioInvent International AB

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BINV Stock
  4. Consensus BioInvent International AB